Concepedia

István Káldor

IK

Statistics

Publications

18

Citations

1.3K

H-Index

16

Active since

1988

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Vertex Pharmaceuticals (United States)

István Káldor is an author at Research Triangle Park Foundation specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1988–2016

18

Publications

18

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen et al. · Journal of Medicinal Chemistry · 1998 · 301 citations · Full text

, , +10

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Kathleen K. Brown, Brad R. Henke, Steven G. Blanchard et al. · Diabetes · 1999 · 168 citations

, , +17

Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064

Adwoa Akwabi-Ameyaw, Jonathan Y. Bass, Richard D. Caldwell et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 139 citations · Full text

, , +13

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors

Curt D. Haffner, J. David Becherer, Eric E. Boros et al. · Journal of Medicinal Chemistry · 2015 · 136 citations · Full text

, , +13

Total Synthesis of the Macrolide Antitumor Antibiotic Lankacidin C

Andrew S. Kende, Kun Liu, István Káldor et al. · Journal of the American Chemical Society · 1995 · 99 citations

, , +8

1–5 of 18